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Objective: To present prenatal diagnosis of mosaic trisomy 15 at amniocentesis.
Materials and methods: A 37-year-old woman underwent amniocentesis at 17 weeks of gestation
because of advanced maternal age. Cytogenetic analysis of cultured amniocytes revealed a karyotype of
47,XY,þ15[2]/46,XY[17]. She was referred for repeated amniocentesis at 19 weeks of gestation. Array
comparative genomic hybridization (aCGH), interphase ﬂuorescence in situ hybridization (FISH) and
quantitative ﬂuorescent polymerase chain reaction assays on uncultured amniocytes, conventional cy-
togenetic analysis and aCGH on cultured amniocytes, and FISH on uncultured urinary cells after birth
were applied. Cordocentesis revealed a karyotype of 46,XY.
Results: At repeated amniocentesis, cultured amniocytes revealed a karyotypes of 46,XY [22 colonies],
FISH on uncultured amniocytes revealed 21.2% (22/104 cells) mosaicism for trisomy 15, aCGH on un-
cultured amniocytes revealed a genomic gain (log2 ratio ¼ 0.3) in chromosome 15, quantitative ﬂuo-
rescent polymerase chain reaction on uncultured amniocytes excluded uniparental disomy 15 (UPD 15),
and aCGH on culture amniocytes revealed no genomic imbalance in chromosome 15. A healthy 3700 g
male baby was delivered at 38 weeks of gestation with no phenotypic abnormalities at age 6 months.
FISH on uncultured urinary cells at birth and at age 6 months revealed mosaic trisomy 15 levels of 20%
(13/65 cells) and 12.2% (6/49 cells), respectively.
Conclusion: Prenatal diagnosis of mosaic trisomy 15 at amniocentesis should alert doctors about the
occurrence of UPD 15 and a clinically signiﬁcant phenotype. The present case provides evidence for
cytogenetic discrepancy between uncultured and cultured amniocytes in mosaic trisomy 15 at amnio-
centesis. It is possible that the abnormal cell lines of amniocytes with trisomy 15 disappear after long-
term cell culture.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.s and Gynecology, Mackay
Road, Taipei, Taiwan.
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bstetrics & Gynecology. PublishedIntroduction
Mosaic trisomy 15 is a rarely described mosaicism at amnio-
centesis and in liveborn children. The common features of pheno-
typic abnormalities in liveborn children with mosaic trisomy 15
include intrauterine growth restriction (IUGR), congenital heart
defects, multiorgan malformations and craniofacial dysmorphism
[1e4]. In case of mosaic trisomy 15, there is an increased risk forby Elsevier Taiwan LLC. All rights reserved.
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disomy 15 (UPD 15)], especially maternal uniparental heterodisomy
for chromosome 15, and PradereWilli syndrome because of
trisomic rescue by reduction to disomy [1,5e9]. In this study, we
present our experience of prenatal diagnosis of mosaic trisomy 15
by amniocentesis and a review of the literature.Materials and methods
Clinical description
A 37-year-old, gravid 2, para 1 woman underwent amniocen-
tesis at 17 weeks of gestation because of advanced maternal age.
Amniocentesis revealed a karyotype of 47,XY,þ15[2]/46,XY[17].
Among the 19 colonies of cultured amniocytes, two colonies had
the karyotype of 47,XY,þ15, whereas the other 17 colonies had a
normal karyotype. She was referred to the hospital for genetic
counseling. The parental karyotypes were normal, and prenatal
ultrasound ﬁndings were unremarkable. Repeated amniocentesis
was performed at 19 weeks of gestation. Array comparative
genomic hybridization (aCGH), interphase ﬂuorescence in situ hy-
bridization (FISH), and quantitative ﬂuorescent polymerase chain
reaction (QF-PCR) assays were applied on uncultured amniocytes,
and conventional cytogenetic analysis and aCGH were applied on
cultured amniocytes. The woman underwent cord blood sampling
at 23 weeks of gestation, which revealed a karyotype of 46,XY in
120 of 120 cells of cultured cord blood lymphocytes. The pregnancy
was uneventful, and at 38 weeks of gestation, a healthy male baby
was delivered with a body weight of 3700 g and a body length of
52.5 cm. The infant was doing well with no phenotypic abnor-
malities, and showed normal growth and psychomotor develop-
ment at 6 months of age as checked by the pediatric specialist in
medical genetics. Interphase FISH analysis on uncultured urinary
cells was performed at birth and at the age of 6 months.aCGH
Whole-genome aCGH on the DNA extracted from either uncul-
tured amniocytes derived from 10 mL of amniotic ﬂuid or cultured
amniocytes was performed using NimbleGen ISCA Plus Cytogenetic
Array (Roche NimbleGen, Madison, WI, USA). The NimbleGen ISCA
Plus Cytogenetic Array has 630,000 probes and amedian resolution
of 15e20 kb across the entire genome. The DNA from amniocytes
was extracted ﬁrst. This was done by following the manufacturer's
protocol of QIAamp DNA Mini kit (Qiagen, Inc., Valencia, CA, USA).
Then, the extracted DNA (0.5 mg) was labeled in Cy5 dye compared
with an equivalent amount of normal female gDNA (G1521;
Promega) labeled in Cy3 dye to perform the aCGH experiment. The
experiment was performed according to the procedures recom-
mended by the Roche NimbleGen ISCA plus Cytogenetic Array's
user guide. The data were ﬁnally represented by using Nexus 6.1
(BioDiscovery, Hawthorne, CA, USA).Figure 1. Interphase ﬂuorescence in situ hybridization (FISH) analysis on uncultured
amniocytes using the 15q11.2-speciﬁc probe of RP11-441B20 [ﬂuorescein isothiocya-
nate (FITC), spectrum green] shows (A) three green signals in a trisomy 15 cell and (B)
two green signals in a disomy 15 cell.QF-PCR
QF-PCR analysis was performed on the DNA extracted from
uncultured amniocytes and parental bloods. Brieﬂy, primers spe-
ciﬁcally ﬂanking short tandem repeat markers on chromosome 15
region such as D15S217 (15q13.1), D15S195 (15q22.2), D15S818
(15q24.1), D15S532 (15q26.1), and D15S816 (15q26.2) were applied
to undertake polymorphic marker analysis to exclude UPD and to
determine the parental origin of genomic imbalance if detected.FISH
Interphase FISH analysis was performed on 104 uncultured
amniocytes using a 15q11.2-speciﬁc bacterial artiﬁcial chromosome
(BAC) probe RP11-441B20 encompassing 25,253,957e25,522,314
(NCBI build 37; spectrum green, ﬂuorescein isothiocyanate) ac-
cording to the standard FISH protocol. The same procedure was
applied on 65 uncultured urinary cells obtained at birth. Interphase
FISH analysis was applied on 49 uncultured urinary cells obtained
at the age of 6 months using a 15q11.2-speciﬁc BAC probe RP11-
307C10 encompassing 22,973,229e23,141,039 (NCBI build 37;
spectrum red, Texas Red) and a 15q26.2-speciﬁc BAC probe RP11-
79C10 encompassing 96,334,910e96,493,808 (NCBI build 37;
spectrum green, ﬂuorescein isothiocyanate).Conventional cytogenetic analysis
Routine cytogenetic analysis by G-banding techniques at the
550 bands of resolution was performed following repeated
amniocentesis. About 20mL of amniotic ﬂuidwas collected, and the
sample was subjected to in situ amniocyte culture. Twenty-two
colonies of cultured amniocytes were investigated.Results
Conventional cytogenetic analysis of cultured amniocytes at
repeated amniocentesis revealed a karyotype of 46,XY in all of the
22 colonies of cultured amniocytes. At repeated amniocentesis,
interphase FISH analysis on uncultured amniocytes showed three
green signals of the 15q11.2-speciﬁc probe of RP11-441B20 in 21.2%
(22/104) of the cells and two green signals in the remaining cells,
indicating a 21.2% mosaicism for trisomy 15 in the uncultured
amniocytes (Figure 1). The normal control database shows three
signals in 0.9% (1/102) of the cells.Whole-genome aCGH analysis on
the DNA extracted from uncultured amniocytes detected a gene
dosage increase of chromosome 15 or arr 15q11.2q26.3
(20,110,602e102,531,392)  2.46 (Figures 2 and 3). The duplicated
segment had a log2 ratio of 0.3, indicating mosaicism in the un-
cultured amniocytes. However, aCGH analysis on the DNA extracted
from the culture amniocytes revealed no genomic imbalance in
chromosome 15, indicating no mosaicism in the cultured amnio-
cytes (Figures 2 and 3). QF-PCR analysis on the DNA extracted from
uncultured amniocytes and parental bloods revealed a biparental
diallelic pattern for the chromosome 15-speciﬁc markers and thus
excluded UPD 15 in the fetus (Figure 4). Interphase FISH analysis on
uncultured urinary cells showed three green signals of RP11-
Figure 2. Array comparative genomic hybridization (aCGH) analysis reveals (A) a small
genomic gain (a log2 ratio of 0.3) in chromosome 15 in uncultured amniocytes, and (B)
no genomic imbalance in chromosome 15 in cultured amniocytes.
Figure 4. Representative electrophoretograms of quantitative ﬂuorescent polymerase
chain reaction assays on the DNA extracted from uncultured amniocytes. The infor-
mative marker D15S195 (15q22.2) shows two peaks of ﬂuorescent activity from two
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three red signals of RP11-307C10 and three green signals of RP11-
79C10 in 12.2% (6/49) of the urinary cells obtained at the age of
6 months (Figure 5).different parental alleles in uncultured amniocytes and thus excludes uniparental
disomy 15.Discussion
Molecular cytogenetic techniques such as aCGH, interphase
FISH, and QF-PCR on uncultured amniocytes for rapid positive
conﬁrmation of trisomy mosaicism have been well described
[10e15]. The present case shows that in case of mosaic trisomy 15Figure 3. The zoom-in view of array comparative genomic hybridizationat amniocentesis, interphase FISH and aCGH on uncultured
amniocytes are useful for conﬁrmation of the presence of mosai-
cism, and QF-PCR assay on uncultured amniocytes is useful for
rapid exclusion of UPD 15. The present case also provides evidence(aCGH) on (A) uncultured amniocytes and (B) cultured amniocytes.
Figure 5. Interphase ﬂuorescence in situ hybridization (FISH) analysis on uncultured
urinary cells using the 15q11.2-speciﬁc probe of RP11-307C10 (Texas Red, spectrum
red) and the 15q26.2-speciﬁc probe of RP11-79C10 [ﬂuorescein isothiocyanate (FITC),
spectrum green] shows (A) three green and three red signals in a trisomy 15 cell, and
(B) two green and two red signals in a disomy 15 cell.
Table 1
Reported cases of mosaic trisomy 15 detected by amniocentesis.
Study Cases Indication Amniocentesis
Gimelli et al [32] 47,XX,þ15/46,XX AMA T15 ¼ 34.6% (26
Retap:
T15 ¼ 28% (25 ce
Worton & Stern [23] Mosaic trisomy 15 d T15 ¼ 5.9% (51 c
Lahdetie & Lakkala [17] 47,XX,þ15/46,XX AMA T15 ¼ 9.9% (81 c
Retap:
T15 ¼ 5.8% (34 c
Sundberg et al [18] 47,XX,þ15/46,XX AMA T15 ¼ 64% (78 co
Milunsky et al [16]
Milunsky et al [5] 47,XX,þ15/46,XX Abnormal
ultrasound, IUGR,
low E3 ¼ 0.38 MoM
T15 ¼ 44.4% (9 c
Rocklin et al [6]
Christian et al [7] 47,XX,þ15/46,XX AMA, previous
child with Down
syndrome
T15 ¼ 44.4% (27
Case 1
Christian et al [7]
Case 2 47,XX,þ15/46,XX AMA T15 ¼ 66% (24 ce
Retap:
T15 ¼ 37% (30 ce
Case 3 47,XY,þ15/46,XY AMA T15 ¼ 6% (50 cel
Markovic et al [19] 47,XX,þ15/46,XX AMA; T15 ¼ 96.7%
(30 cells) by CVS
T15 ¼ 36% (50 ce
Retap:
T15 ¼ 29% (31 ce
Zaslav et al [20]
Zaslav et al [21] 47,XX,þ15/46,XX AMA T15 ¼ 5.1% (39 c
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amniocytes with a favorable fetal outcome. In the present case, the
ﬁrst amniocentesis revealed 10.5% (2/19 colonies) mosaicism for
trisomy 15 in cultured amniocytes, but the second amniocentesis
revealed no (0/22 colonies) mosaicism for trisomy 15 in cultured
amniocytes, indicating that different amniocenteses may report in
inconsistent mosaic trisomy 15 levels in cultured amniocytes,
making genetic counseling even more difﬁcult. The present case
additionally provides evidence for cytogenetic discrepancy be-
tween uncultured amniocytes and cultured amniocytes in mosaic
trisomy 15 at amniocentesis. At repeated amniocentesis in this case,
uncultured amniocytes revealed ~ 21.2% mosaicism for trisomy 15
by interphase FISH, and < 30% mosaicism by aCGH, whereas in
cultured amniocytes, no mosaic trisomy 15 was detected by con-
ventional cytogenetic analysis and aCGH study. It is possible that
the abnormal cell lines of amniocytes with trisomy 15 disappear
after long-term cell culture. We suggest that application ofConﬁrmatory studies Outcome & phenotype
cells)
lls)
Skin: T15 ¼ 56% (41 cells)
Lung: T15 ¼ 29.4% (17 cells)
Left kidney: T15 ¼ 14.8% (74 cells)
Right kidney: T15 ¼ 0% (23 cells)
Intestine: T15 ¼ 15% (20 cells)
Top; facial dysmorphism, CHD
(persistent common AV canal),
malrotation of intestine,
abnormal rib numbers (13 ribs)
ells) Blood: T15 ¼ 0% (50 cells) Normal liveborn
ells)
ells)
Placenta: T15 ¼ 92.4% (198 cells)
Membrane: T15 ¼ 47.1% (17 cells)
Cord: T15 ¼ 8.3% (121 cells)
Cord blood: T15 ¼ 0% (100 cells)
IUGR, oligohydramnios,
delivered at 37 wk, 1420 g; CHD
(hypoplastic left ventricle,
mitral atresia, subvalvular
aortic stenosis, ASD, VSD), died
at age 13 d
lonies) Cord blood: T15 ¼ 5.6% (54 cells)
Cord: T15 ¼ 56% (25 cells)
Skin: T15 ¼ 72% (25 cells)
Membrane: T15 ¼ 0% (30 cells)
Prenatal ultrasound: mitral
atresia, VSD, a hypoplastic left
heart, TOP
olonies) Blood: T15 ¼ 0% (100 cells)
Skin: T15 ¼ 80% (50 cells)
Lung: T15 ¼ 85% (20 cells)
Blood DNA: maternal UPD 15
IUGR, delivery at 38 wk; 1700 g,
facial dysmorphism, CHD (VSD,
PDA), hypotonia, abnormal ribs
(13 ribs), overlapping ﬁngers
with hypoplastic nails; died at
age 6 wk
cells) Skin: T15 ¼ 100% (10 cells)
Lung: T15 ¼ 100% (10 cells)
Kidney: T15 ¼ 100% (10 cells)
Membrane: T15 ¼ 30% (10 cells)
Cord blood: T15 ¼ 18% (189 cells)
DNA: maternal UPD 15
TOP; a two-vessel cord,
malrotataion of the bowel
lls)
lls)
CVS (direct): T15 ¼ 33% (6 cells)
(culture): T15 ¼ 100% (6 cells)
Cord blood: T15 ¼ 17% (30 cells)
Skin: T15 ¼ 40% (20 cells)
DNA: no UPD 15
IUGR, TOP; extension
contraction of metacarpal
ephalangeal joints on both
upper extremities, low-set ears,
arrhinencephaly
ls) Retap:
DNA: no UPD 15
PCR: no mosaicism
Delivery at 28 wk; normal
lls)
lls)
Heart blood: T15 ¼ 23.5% (51 cells)
Left kidney: T15 ¼ 6% (50 cells)
Right kidney: T15 ¼ 9.2% (54 cells)
Intestine: T15 ¼ 44.4% (54 cells)
Skin: T15 ¼ 42.6% (54 cells)
FISH: no UPD 15
TOP; craniofacial dysmorphism,
brachycephaly
olonies) Lung: T15 ¼ 2% (50 cells)
Heart: T15 ¼ 8% (50 cells)
Placenta: T15 ¼ 100% (50 cells)
Skin: T15 ¼ 6% (50 cells)
FISH
Amniotic ﬂuid: T15 ¼ 19% (75 cells)
Abnormal ultrasound: IUGR, a
hypoplastic right ventricle;
TOP; single umbilical artery
(continued on next page)
Table 1 (continued )
Study Cases Indication Amniocentesis Conﬁrmatory studies Outcome & phenotype
Lung: T15 ¼ 5% (100 cells)
Heart: T15 ¼ 15% (100 cells)
Placenta: T15 ¼ 95% (100 cells)
Skin: T15 ¼ 10% (100 cells)
DNA: no UPD 15
Hsu et al [9]
Case XIII-5 47,XY,þ15/46,XY d T15 ¼ 31.2% (48 cells) d Normal abortus
Case XIII-8 47,XX,þ15/46,XX AMA T15 ¼ 39.3% (28 cells) Skin: T15 ¼ 20% (10 cells)
Cord: T15 ¼ 50% (10 cells)
Villi: T15 ¼ 44.4% (9 cells)
Membrane: T15 ¼ 60% (10 cells)
DNA: maternal UPD 15
TOP; abnormal abortus, IUGR
Case XIII-9 47,XX,þ15/46,XX Positive MSAFP
proﬁle
T15 ¼ 6.1% (49 cells) Blood: T15 ¼ 0% (30 cells)
Placenta: T15 ¼ 0% (30 cells)
Normal liveborn
Case XIII-11 47,XY,þ15/46,XY d T15 ¼ 3.6% (83 cells)
Retap:
T15 ¼ 1% (200 cells)
Cord blood: T15 ¼ 0% (200 cells)
Placenta: T15 ¼ 72% (50 cells)
Amnion: T15 ¼ 86% (50 cells)
Chorion: T15 ¼ 91% (45 cells)
Cord: T15 ¼ 6% (50 cells)
Normal liveborn
Hansson et al [22] 45,X/47,XY,þ15/46,XY Anxiety T15 ¼ 10.5% (19 colonies)
45,X ¼ 10.5% (19 colonies)
Retap:
T15 ¼ 3.8% (26 colonies)
45,X ¼ 50% (26 colonies)
Cord blood: T15 ¼ 0% (30 cells)
45,X ¼ 0% (30 cells)
Lung: T15 ¼ 20% (30 cells)
45,X ¼ 20% (30 cells)
Kidney: T15 ¼ 0% (25 cells)
45,X ¼ 44% (25 cells)
Fasia: T15 ¼ 12% (25 cells)
45,X ¼ 28% (7 cells)
Placenta: T15 ¼ 36% (25 cells)
45,X ¼ 44% (25 cells)
DNA: no UPD 15
TOP; normal abortus
Present case 47,XY,þ15/46,XY AMA T15 ¼ 10.5% (19 colonies)
Retap:
T15 ¼ 0% (22 colonies)
FISH (uncultured
amniocytes):
T15 ¼ 21.2% (104 cells)
aCGH (uncultured
amniocytes):
T15 log2 ratio ¼ 0.3
aCGH (cultured
amniocytes):
no genomic imbalance
QF-PCR: (uncultured
amniocytes): no UPD 15
Cord blood: T15 ¼ 0% (120 cells)
FISH (uncultured urinary cells):
At birth: T15 ¼ 20% (65 cells)
At age 6 mo: T15 ¼ 12.2% (49 cells)
Delivery at 38 wk; 3700 g.
Normal at birth & at age 6 mo
d¼ not available; aCGH¼ array comparative genomic hybridization; AMA¼ advancedmaternal age; ASD¼ atrial septal defect; AV¼ atrioventricular, CHD¼ congenital heart
defect; CVS ¼ chorionic villus sampling; E3 ¼ estriol; FISH ¼ ﬂuorescence in situ hybridization; IUGR ¼ intrauterine growth restriction; MoM ¼ multiples of the median;
MSAFP ¼ maternal serum a-fetoprotein; PCR ¼ polymerase chain reaction; PDA ¼ patent ductus arteriosus; QF-PCR ¼ quantitative ﬂuorescent polymerase chain reaction;
T15 ¼ trisomy 15; TOP ¼ termination of pregnancy; UPD ¼ uniparental disomy; VSD ¼ ventricular septal defect.
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amniocentesis for mosaic trisomy 15 is very practical for deter-
mining the real mosaic level under such a circumference.
To date, at least 16 cases (including this case) of mosaic trisomy
15 detected by amniocentesis have been reported (Table 1). Of
these, at least 9 cases (9/15 ¼ 56.3%) [5e7,9,16e22,32] were asso-
ciated with prominent phenotypic abnormalities, suggesting that
the malformation risk should be given consideration in prenatal
diagnosis of mosaic trisomy 15 by amniocentesis. In the 9 cases
with an apparently abnormal outcome, the percentage of trisomic
cells in cultured amniocytes varied from 5.1% to 66% (with 7 cases
28%). In the seven cases with a normal outcome, the percentage of
trisomic cells in cultured amniocytes varied from 1% to 31.2% (with
4 cases  6.1%). These ﬁndings indicate a correlation between a
higher trisomy 15 mosaicism level and an abnormal fetal outcome.
Table 1 shows that the male/female sex ratio for fetal mosaic
trisomy 15 is 0.5 (5 males/10 females), indicating a female pre-
ponderance in fetal mosaic trisomy 15. Table 1 also shows that
mosaic trisomy 15 can prenatally be associated with elevated
maternal serum a-fetoprotein [9], decreased maternal serumestriol [5,16], and abnormal ultrasound ﬁndings [5,7,9,16e18,20,21].
The reported abnormal ultrasound ﬁndings associated with mosaic
trisomy 15 at amniocentesis include IUGR, oligohydramnios, and
congenital heart defects. In the present case, the cord blood sam-
pling revealed a normal karyotype. Table 1 shows a limitation of
application of cord blood sampling for the conﬁrmation of mosaic
trisomy 15 detected by amniocentesis [5,9,16,17,22,23]. At least
three cases in Table 1 were associated with maternal UPD 15
[5e7,9,16]. Therefore, in case of mosaic trisomy 15 detected by
amniocentesis, the UPD testing to detect maternal uniparental
disomy, particularly heterodisomy for chromosome 15, should be
considereddespecially when cord blood sampling or repeated
amniocentesis reveals a normal karyotype. Maternal UPD 15 and
paternal UPD 15 are syndromic [24,25]. Maternal UPD 15 is asso-
ciated with PradereWilli syndrome, which is characterized by
muscular hypotonia, feeding difﬁculties, hyperphagia, obesity,
moderate mental retardation, facial dysmorphisms, short hands
and feet, and hypogonadotropic hypogonadism [24,25]. Paternal
UPD 15 is associated with Angelman syndrome, which is charac-
terized by seizures, electroencephalographic abnormalities, ataxia,
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laughter [24,25].
To date, at least 12 cases (4 males/8 females) of liveborn cases
with mosaic trisomy 15 have been reported [1e5,16,17,26e31]. The
observed abnormalities associated with mosaic trisomy 15
included IUGR, craniofacial dysmorphisms; renal anomalies of
small dysplastic kidneys and bilateral pelviectasis; brain anomalies
of hypoplastic cerebellum, ventricular asymmetry, lenticulostriate
vasculopathy, and defects of anterior interhemispheric falx; genital
anomalies of anteriorly placed anus, hypoplastic labia majora, un-
descended testis, hypoplastic scrotum, and small penis; congenital
heart defects of ventricular septal defect, coarctation of aorta, hy-
poplastic left ventricle, mitral atresia, subvalvular aortic stenosis,
atrial septal defect, patent ductus arteriosus, mitral stenosis, and
pulmonary stenosis; digit anomalies, and pigmentary abnormal-
ities [4]. The present case has 20% mosaicism for trisomy 15 in the
uncultured amniocytes and the urinary cells at birth, but presented
no phenotypic abnormalities at the age of 6 months at follow-up.
In summary, we present prenatal diagnosis and molecular cy-
togenetic analysis of mosaic trisomy 15 using uncultured and
cultured amniocytes in a pregnancy with a favorable fetal outcome.
We demonstrate the usefulness of analyses of uncultured amnio-
cytes by interphase FISH and aCGH for rapid conﬁrmation of low-
level trisomy 15 mosaicism at amniocentesis, and by QF-PCR for
rapid exclusion of UPD 15.
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